| Gland Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543245 |
NSE Symbol : GLAND |
P/E(TTM) : 35.72 |
|
ISIN Demat : INE068V01023 |
Div & Yield% : 0.65 |
EPS(TTM) : 85.60 |
|
Book Value(₹) : 655.11 |
Market Cap(₹Cr) : 50,448.77 |
Face Value(₹) : 1.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 1,286.64 | 1,261.59 | 1,177.51 | 1,074.15 | 1,038.84 | 1,030.35 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,286.64 | 1,261.59 | 1,177.51 | 1,074.15 | 1,038.84 | 1,030.35 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 58.82 | 106.36 | 60.21 | 82.59 | 54.74 | 43.72 |
| Total Income | 1,345.46 | 1,367.95 | 1,237.72 | 1,156.74 | 1,093.58 | 1,074.07 |
| Total Expenditure | 813.13 | 753.88 | 780.23 | 699.27 | 679.99 | 636.23 |
| PBIDT | 532.33 | 614.07 | 457.49 | 457.48 | 413.59 | 437.84 |
| Interest | 0.69 | 6.17 | 0.50 | 3.97 | 7.44 | 3.45 |
| PBDT | 531.64 | 607.91 | 456.99 | 453.51 | 406.15 | 434.40 |
| Depreciation | 43.95 | 43.11 | 44.53 | 44.84 | 43.77 | 43.07 |
| Tax | 125.19 | 143.21 | 110.21 | 105.90 | 93.27 | 99.07 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -1.89 | 1.13 | -5.60 | 0.78 | -0.15 | 2.25 |
| Reported Profit After Tax | 364.39 | 420.45 | 307.85 | 302.00 | 269.26 | 290.00 |
| Extra-ordinary Items | 0.00 | 0.00 | -17.84 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 364.39 | 420.45 | 325.69 | 302.00 | 269.26 | 290.00 |
| EPS (Unit Curr.) | 22.11 | 25.52 | 18.68 | 18.33 | 16.34 | 17.60 |
| EPS (Adj) (Unit Curr.) | 22.11 | 25.52 | 18.68 | 18.33 | 16.34 | 17.60 |
| Calculated EPS (Unit Curr.) | 22.09 | 25.52 | 18.68 | 18.33 | 16.34 | 17.60 |
| Calculated EPS (Adj) (Unit Curr.) | 22.09 | 25.52 | 18.68 | 18.33 | 16.34 | 17.60 |
| Calculated EPS (Ann.) (Unit Curr.) | 88.36 | 102.08 | 74.74 | 73.32 | 65.37 | 70.41 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 88.36 | 102.08 | 74.74 | 73.32 | 65.37 | 70.41 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 16.50 | 16.48 | 16.48 | 16.48 | 16.48 | 16.48 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 41.37 | 48.67 | 38.85 | 42.59 | 39.81 | 42.49 |
| PBDTM(%) | 41.32 | 48.19 | 38.81 | 42.22 | 39.10 | 42.16 |
| PATM(%) | 28.32 | 33.33 | 26.14 | 28.12 | 25.92 | 28.15 |
